FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was ...
Data Trends provide quick, visually memorable data-driven information and insights that are useful in clinical practice. Here, we explore recent treatment updates in chronic lymphocytic leukemia (CLL) ...
A phase 3 trial evaluates the efficacy and safety of nilotinib with pegylated interferon alfa-2a in patients with newly ...
"I know physicians are busy, but I’m treating a patient, not a disease. I take a holistic approach. I think we need to make physicians who treat chronic myeloid leukemia treat the disease and make ...
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for ...
A CML diagnosis, often striking young Indian adults, is now more manageable. This guide emphasizes empowering patients by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results